Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
GenFleet Announces First Patient Dosed in Phase Ib/II Trial of TGF-β R1 Inhibitor in Combination with PD-1 Inhibitor in Global Multi-center Research 2021-10-21 08:05
Senhwa Presents Positive Initial Data from Phase 2 Clinical Trial of Silmitasertib (CX-4945) in Moderate COVID-19 Patients At the ISIRV-WHO Conference 2021-10-20 20:52
Alterity Therapeutics Announces Expanded ATH434 Phase 2 Clinical Development Program 2021-10-20 05:08
InnoCare Announces Approval of Clinical Trial of Novel SHP2 Allosteric Inhibitor ICP-189 in China 2021-10-19 12:56
The Journal of Medicinal Chemistry Publishes Study Showing Potential of the Potent EED Inhibitor EEDi-5273 (APG-5918) to Achieve Complete Tumor Regression by Modulating the Epigenetics 2021-10-18 22:42
I-Mab Announces IND Approval for Phase 2 Clinical Trial of Efineptakin Alfa in Combination with PD-1 Therapy in China 2021-10-18 20:00
Akeso is Rapidly Advancing The Phase II Clinical Trial of IL-4R Monoclonal Antibody (AK120) for the Treatment of Atopic Dermatitis and Asthma 2021-10-15 12:44
I-Mab Advances Late-stage Development of Its Differentiated CD38 Antibody Felzartamab (TJ202) in China 2021-10-13 20:00
Shanghai, industry partners to co-build world-class biopharma industry cluster 2021-10-13 19:43
The CDE Approved IND Application to Investigate Combination of Asieris' APL-1202 and BeiGene's Tislelizumab as Neoadjuvant Therapy for MIBC Patients 2021-10-13 15:47
Accelerate Innovation Towards the Future，SAB of Winhealth Pharma Formally Established 2021-10-12 23:45
CBC-backed Jadeite Medicines Announces Exclusive Licensing Agreement with Albireo Pharma to Develop and Promote Odevixibat in Japan 2021-10-12 20:30
Shanghai Pharmaceuticals and Luca Healthcare Announce a Strategic Collaboration to Provide Home Drug Delivery to Rare Disease Patients on Luca Healthcare's Patient Management Platform 2021-10-12 19:21
Kintor Pharma Announces China NMPA Approves Clinical Trial of ALK-1 and Nivolumab Combination Therapy for the First-line Treatment of Advanced Hepatocellular Carcinoma 2021-10-11 13:00
Winhealth-CARD Cooperation Boosts Rare Disease Healthy Ecosystem Construction 2021-10-08 23:01
Kazia Therapeutics to Present at LD Micro Main Event 2021-10-06 22:00
I-Mab and ABL Bio to Present Preclinical Data of TJ-CD4B/ABL111 and TJ-L14B/ABL503 at the 2021 SITC Annual Meeting 2021-10-05 20:00
Pharmaxis Cleared To Progress To Phase 2 Bone Marrow Cancer Trial 2021-10-05 18:00
Kintor Pharma Announces First Patient Dosing in Phase III Clinical Trial of Proxalutamide for the Treatment of Hospitalized COVID-19 Patients in US 2021-10-04 16:30
I-Mab Announces Upcoming Participation at October Conferences 2021-10-01 20:00
1 95 96 97 98 99 165